You will receive a lab slip and take it to any Lab Corp draw center close to home
Some individuals achieve satisfactory results here and do not need to escalate further
With such a large presence in the media, it seems like everyone is successfully losing weight with these medications
Unfortunately, these are the only real randomly controlled trials we're aware of to date
While the findings are encouraging, prospective clinical trials will be needed before GLP-1 drugs could be considered part of AMD prevention or treatment strategies
Key drivers behind GLP-1 and addiction research include: Rapid expansion in the use of GLP-1 medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Maunjaro and Zepbound) Reports of changes in cravings, alcohol use, or reward-seeking behaviors beyond weight loss Increased public conversation and clinical curiosity about psychological and behavioral effects Scientific interest in GLP-1 activity within reward pathways and dopamine signaling Recognition that appetite regulation and addiction involve shared neural mechanisms This research is still emerging, and findings should be interpreted with caution
